| E-Y0000383 |
EP |
【全消旋-α-生育酚 |
All-rac-alpha-tocopherol for peak identification |
|
50 mg |
1264 |
28 |
| E-Y0000384 |
EP |
【全消旋-α-生育酚 |
All-rac-alpha-tocopheryl acetate for peak identification |
|
30 mg |
1264 |
28 |
| E-Y0000385 |
EP |
【1,4-山梨糖醇（訂貨 |
1,4-Sorbitan |
|
50 mg |
1264 |
28 |
| E-Y0000386 |
EP |
【茴香苷峰值鑒別用 |
Foeniculin for peak identification |
|
100 mg |
1264 |
28 |
| E-Y0000387 |
EP |
【八角茴香油峰值鑒 |
Pseudoisoeugenyl 2-methylbutyrate for peak identification |
|
100 mg |
1264 |
28 |
| E-Y0000388 |
EP |
【新城疫疫苗（滅活）BR |
Newcastle Disease Vaccine (inactivated) BRP |
|
40 mg |
3100.59 |
42 |
| E-Y0000389 |
EP |
【乙肝疫苗（基因）BRP |
Hepatitis B vaccine (「DNA) BRP method A (thiomersal free) |
|
0.5 ml |
1660.59 |
42 |
| E-Y0000390 |
EP |
【奧昔拉定雜質D（訂 |
Oxeladin impurity D |
|
20 mg |
1264 |
28 |
| E-Y0000391 |
EP |
Betahistine dihydrochloride |
|
50 mg |
1264 |
28 |
| E-Y0000392 |
EP |
【氯氰碘柳胺鈉二水 |
Closantel sodium dihydrate |
|
20 mg |
1264 |
28 |
| E-Y0000393 |
EP |
【氯氰碘柳胺系統(tǒng)適 |
Closantel for system suitability |
|
20 mg |
1264 |
28 |
| E-Y0000394 |
EP |
【地匹福林系統(tǒng)適應 |
Dipivefrine for system suitability |
|
10 mg |
1264 |
28 |
| E-Y0000395 |
EP |
【格拉司瓊雜質E（訂 |
Granisetron impurity E |
|
15 mg |
1264 |
28 |
| E-Y0000396 |
EP |
【鹽酸格拉司瓊（訂貨 |
Granisetron hydrochloride |
|
120 mg |
1264 |
28 |
| E-Y0000397 |
EP |
【醋酸賴氨酸（訂貨以 |
Lysine acetate |
|
60 mg |
1264 |
28 |
粵公網(wǎng)安備 44010302000979號
